Zhejiang Tailin BioEngineeringLtd Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Da Lin Ye

Geschäftsführender

CN¥606.5k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	52.1%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.7yrs

Jüngste Management Updates

Recent updates

What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Oct 08

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

May 09

Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

Mar 08

Geschäftsführer

Da Lin Ye (64 yo)

no data

Amtszeit

CN¥606,500

Vergütung

Mr. Da Lin Ye serves as Chairman and General Manager at Zhejiang Tailin BioEngineering Co.,Ltd.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Da Lin Ye	GM & Chairman	no data	CN¥606.50k	52.07% CN¥ 1.2b
Zhi Lin Shen	Deputy GM & Director	no data	CN¥1.15m	0.82% CN¥ 19.2m
Xin Qun Xia	Deputy GM & Director	no data	CN¥1.18m	1.05% CN¥ 24.6m
Wei Ju Ni	Director	no data	keine Daten	5.68% CN¥ 132.5m
Jian Gang Mo	Manager of Analytical Instruments Business Department & Member of Supervisory Board	no data	CN¥315.60k	keine Daten
Mei Zhu Hu	Manager of Life Science Research & Development & Employee Representative to the Supervisory Board	no data	CN¥222.30k	keine Daten
Xiaolu Ni	Chairman of the Supervisory Board & GM of Business Unit	3.7yrs	CN¥257.60k	keine Daten
Ming Dong	Independent Director	4.5yrs	CN¥80.00k	keine Daten
Zhongzhi Yang	Independent Director	5.4yrs	CN¥80.00k	keine Daten
Ya Ni	Independent Director	1.6yrs	CN¥60.00k	keine Daten
Xunlong Chen	Non-Employee Supervisor	less than a year	keine Daten	keine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrener Vorstand: 300813Die Vorstandsmitglieder gelten als erfahren (3.7 Jahre durchschnittliche Amtszeit).

Zhejiang Tailin BioEngineeringLtd Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Zhejiang Tailin BioEngineering Co.,Ltd, Annual General Meeting, May 14, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: CN¥0.039 (vs CN¥0.019 loss in 3Q 2023)

What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Zhejiang Tailin BioEngineering Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024

New major risk - Revenue and earnings growth

Second quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.05 in 2Q 2023)

Zhejiang Tailin BioEngineering Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Zhejiang Tailin BioEngineering Co.,Ltd, Annual General Meeting, May 14, 2024

New minor risk - Profit margin trend

Investor sentiment deteriorates as stock falls 26%

Investor sentiment improves as stock rises 20%

Zhejiang Tailin BioEngineering Co.,Ltd to Report Q1, 2024 Results on Apr 24, 2024

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Zhejiang Tailin BioEngineering Co.,Ltd to Report Fiscal Year 2023 Results on Apr 24, 2024

Third quarter 2023 earnings released: CN¥0.019 loss per share (vs CN¥0.15 profit in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.16 in 2Q 2022)

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.22 in 2Q 2021)

Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022

First quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.18 in 1Q 2021)

Less than half of directors are independent

Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021

Full year 2021 earnings released: EPS: CN¥1.22 (vs CN¥0.95 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.28 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.22 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021

Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020

Full year 2020 earnings released: EPS CN¥0.95 (vs CN¥0.88 in FY 2019)

New 90-day low: CN¥39.65

New 90-day low: CN¥40.01

Investor sentiment deteriorated over the past week

New 90-day low: CN¥46.35

New 90-day low: CN¥52.83

New 90-day low: CN¥60.04

Third quarter earnings released

First half earnings released

Zhejiang Tailin BioEngineering Co.,Ltd to Report First Half, 2020 Results on Aug 28, 2020

Geschäftsführer

Amtszeit

Vergütung

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter